Investing in tomorrow's medicine
Mérieux Equity Partners is a global investment platform specialized in the healthcare & nutrition sector, working alongside entrepreneurs and companies with ambitious growth plan, offering them privileged access to sector-expertise and industrial network.
News
Twist Bioscience launches Long Oligos to fuel drug development, DNA data storage and gene editing research
29/07/2019
At up to 300 bases, or nucleotides, in length this is the longest commercial oligo offering by continuous chemical synthesis in the industry.
CEVA COMPLETES ACQUISITION OF IDT VETERINARY BUSINESS ASSETS, MOVING CLOSER TO ITS 2020 OBJECTIVE OF 50:50 BIO-PHARMA SPLIT
03/07/2019
Ceva and IDT have successfully completed the acquisition of IDT’s veterinary biopharmaceutical and R&D activities by Ceva.
SuperSonic Imagine announces that it has received a binding offer from the Hologic group to acquire 100% of the Company’s capital for a price of €1.50 per share
21/06/2019
Hologic is planning to acquire a controlling stake of approximately 46% of the Company’s capital.
Key figures
25
21
525
(€ million)
3
